Perk Pressure Based Judgment = Huge Fine

by Hal Mooz 8. May 2012 09:40

Abbott Laboratories to pay $1.6 billion over misbranding drug

Washington (CNN) -- Abbott Laboratories has pleaded guilty and agreed to pay $1.6 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote, the U.S. Justice Department said Monday. Acting Associate Attorney General Tony West said it was case of Abbott putting "profits ahead of patients.

The company admitted that from 1998 through 2006, it "maintained a specialized sales force trained to market Depakote in nursing homes for the control of agitation and aggression in elderly dementia patients, despite the absence of credible scientific evidence that Depakote was safe and effective for that use," the Justice Department said in a news release.

"In addition, from 2001 through 2006, the company marketed Depakote in combination with atypical antipsychotic drugs to treat schizophrenia, even after its clinical trials failed to demonstrate that adding Depakote was any more effective than an atypical antipsychotic alone for that use."

http://www.cnn.com/2012/05/07/justice/abbott-fine-drug/index.html?hpt=hp_t3

 

 

 

 

Tags:

Add comment

  Country flag

biuquote
  • Comment
  • Preview
Loading

About Hal Mooz

Engineer, Project Manager, Entrepreneur, Author, Trainer, Lecturer, Thought Leader, Consultant

Month List

RecentPosts